Novo Nordisk A/S ADR buy TD Cowen
Start price
19.08.25
/
50%
€47.20
Target price
19.08.26
€60.08
Performance (%)
-13.03%
Price
07:30
€41.05
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -13.03%. This prediction currently runs until 19.08.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -0.242% | -0.242% |
| iShares Core DAX® | 0.388% | 0.145% |
| iShares Nasdaq 100 | 1.307% | -2.548% |
| iShares Nikkei 225® | -0.463% | 6.891% |
| iShares S&P 500 | 1.314% | -1.163% |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at TD Cowen from $105.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24
